INTRODUCTION
============

Chronic kidney disease (CKD) affects many organs and systems, leading to exercise intolerance due to the musculoskeletal system impairments. As a consequence, physical inactivity, functional capacity and quality of life declines are commonly reported in this population ([@b2-jer-14-5-883]; [@b7-jer-14-5-883]; [@b20-jer-14-5-883]).

Muscle weakness, especially involving lower limbs is a consequence of persistent uremia from CKD patients, which is aggravated by a sedentary lifestyle ([@b12-jer-14-5-883]). On the other hand, training programs with endurance or strength exercises have been proposed to CKD patients undergoing hemodialysis (HD) ([@b13-jer-14-5-883]; [@b37-jer-14-5-883]). However, in clinical practice, some training protocols are difficult to be supported by CKD patients, owing to the exercise intensity and/or patient limitations, as the clinical condition or the presence of comorbidities.

Whole body vibration (WBV) is an alternative method for strength and neuromuscular training ([@b28-jer-14-5-883]). Improvements in neuromuscular performances with WBV training are related to tonic vibration reflex (TVR), which involve muscle spindles and fast-adapting mechanoreceptors ([@b32-jer-14-5-883]). WBV has shown promising results in muscle performance for elderly ([@b5-jer-14-5-883]) and for a wide range of patients, as Parkinson disease patients ([@b19-jer-14-5-883]), multiple sclerosis ([@b35-jer-14-5-883]), stroke ([@b27-jer-14-5-883]), cystic fibrosis ([@b31-jer-14-5-883]), and chronic obstructive pulmonary disease patients ([@b18-jer-14-5-883]).

Furthermore, WBV training has emerged as an interesting alternative to reduce risk of fall in older adults ([@b21-jer-14-5-883]). In fact, a recent study showed a significant reduction of falls risk from elders submitted to 8 weeks of WBV training ([@b41-jer-14-5-883]). Interestingly, CKD patients undergoing HD have a high risk of falling, leading to suggestions regarding the prevention strategies to this population ([@b14-jer-14-5-883]) and the WBV training could be proposed as an promising intervention.

In daily life activities, many motor responses, such as the prevention of falls, are characterized by a rapid force development (0--200 msec). This reaction time is considerably shorter than the time required (between 400--600 msec) to reach the peak or maximum force ([@b1-jer-14-5-883]). In this context, the ability to develop force at the beginning of a muscle contraction, also known as explosive force, may be functionally more important than peak force ([@b34-jer-14-5-883]).

Notwithstanding, it was identified that explosive force decline earlier ([@b34-jer-14-5-883]) and is better correlated with functional mobility, than the peak force in healthy elders ([@b8-jer-14-5-883]). Additionally, compared to the peak force, explosive force has shown a better ability to predict falls among elders ([@b36-jer-14-5-883]). Thus, use of strategies focused to increase the explosive force may be important in patients with CKD.

Some studies have demonstrated increase in explosive force after an exercise training period for elders ([@b38-jer-14-5-883]; [@b40-jer-14-5-883]), however no studies were found evaluating the effects of WBV training on explosive force in CDK patients.

Therefore, the aim of this study was to investigate whether three months of WBV training increases the explosive force in CKD patients undergoing HD.

MATERIALS AND METHODS
=====================

A randomized controlled pilot trial with blinding of evaluators, participants and statistician was conducted. The study protocol was approved by the institutional committee and the protocol (CAAE: 35872014.8.0000.5208) complied with the Declaration of Helsinki and informed consent was obtained from all participants (Clinical Trials No. NCT02413073).

After randomization in online software ([randomization.com](http://randomization.com)), all eligible participants were allocated to one of the groups: WBV or sham. The confidentiality (allocation concealment) was done using black envelopes, opaque, sealed and numbered, prepared by a researcher not involved in the study. Both patients who were in the WBV group and sham group received the same training protocol on the vibrating platform. In the sham group the platform was connected with the display lit, but without vibration, only with the engine noise that reproduced the sound of vibration. The explosive force obtained from a maximum isometric voluntary contraction (MIVC) was considered as an outcome measure.

Subjects
--------

During the period available for collection (2 years), fourteen CKD patients voluntarily (consecutive sample) participated in the study according to the inclusion criteria: hemodynamically stable (systolic blood pressure ≤140 mmHg, diastolic blood pressure ≤90 mmHg, and heart rate ≤80 bpm), in stage 5 or undergoing HD treatment for at least 3 months and without the musculoskeletal impairments that hamper the performance of tests and/or training. Initially, baseline characteristics of sociodemographic, anthropometric and laboratory data from selected patients were recorded ([Table 1](#t1-jer-14-5-883){ref-type="table"}). The groups were comparable for all variables, except for creatinine values.

Patients with pacemaker, screws and/or pins in the body, acute migraine episodes, cognitive deficits, visual and/or hearing impairment that could limit the evaluation procedures and/or training were excluded; patients classified as physically active according to the International Physical Activity Questionnaire, history of heart surgery, higher body weight than supported by the used vibratory platform (over 120 kg), and using any medication that were not the usual for HD and common comorbidities (diabetes mellitus, hypertension) were also excluded. The study was conducted from April 2015 to February 2016. [Fig. 1](#f1-jer-14-5-883){ref-type="fig"} shows the flow of participants in the study.

Peak force and explosive force recording and analysis
-----------------------------------------------------

It was performed by a blinded evaluator on the dominant limb and in a sitting position, with hip and knee positioned at 90° of flexion. To choose the dominant limb, the individual told with which leg he/she kicks better. An anklet was adapted to the patient and was associated with a strain gauge (Model 830C, EMG System, São Paulo, Brazil) with capacity for 2000 N connected to an acquisition system (EMG System). Recordings were sampled at 2 kHz and subjects were carefully instructed to perform a isometric knee extension "as fast and forcefully as possible" after the command "go," sustaining the contraction for 5 to 7 sec, when the command "stop" was given.

Each volunteer carried out three MIVC with 1-min rest interval between them. For registration purposes, we adopted the average of three movements that did not exceed 10% difference among them. Strength data were collected before and three months after training.

The strain gauge signal was smoothed by a digital fourth-order, zero-lag Butterworth filter, with a cutoff frequency of 15 Hz ([@b1-jer-14-5-883]). Contractile impulse (CImp) and rate of force development (RFD) were obtained as the explosive force parameters, since they are complementary ways to measure the capacity to increase force in short-time periods ([@b34-jer-14-5-883]). Clam was obtained as the cumulated area under the force--time curve, which reflects the entire time history of the contraction. The RFD was obtained as the average slope of the force--time curve (Δforce/Δtime) over the time intervals of 0--30, 0--50, 0--100, and 0--200 msec relative to the onset of contraction ([@b1-jer-14-5-883]).

Onset of muscle contraction was defined as the time point at which the force curve exceeded the baseline by 2.5% of the difference between baseline force and the maximum voluntary contraction (i.e., maximum extension knee force) ([@b1-jer-14-5-883]). RFD was normalized (relative RFD \[RFDr\]) by MIVC (%MIVC/sec) and calculated at the same time epochs used for RFD ([@b26-jer-14-5-883]). All analyses were conducted using specific algorithms. [Table 2](#t2-jer-14-5-883){ref-type="table"} presents the baseline (i.e., data obtained previously to the training or sham period) values and post WBV training values for explosive force parameters.

Intervention
------------

Participants received individual training in a ventilated and air-conditioned room, with sessions lasting about one hour per patient. The WBV training was developed on a vibrating platform (Power Plate MY3, London, UK) with vertical vibration, 35 Hz fixed frequency and amplitude of 2 mm and/or 4 mm. The protocol was implemented during a 3-month period with two sessions per week, and on alternate days to patients' HD. The range was 2 mm in the first 2 weeks, and 4 mm in the following days, and the vibration time increased from 10 min to 15 min to 20 min in the first, second and third months, respectively.

The WBV session consisted of 1-min vibration bouts, interspersed with 30 sec of passive rest ([@b37-jer-14-5-883]). The patient stood on the platform and remained in a semisquat static position (knees at 30° flexion; measured with goniometer) during vibration period, and the upper limb contralateral to the arteriovenous fistula, slightly flexed while supporting on the platform and with feet 20 cm apart ([@b9-jer-14-5-883]). During rest the patients were able to extend the knees to relax.

Before each training session the patient performed active stretching of scalene, sternocleidomastoid, hamstring and quadriceps. Blood pressure, heart rate, peripheral oxygen saturation and the perceived effort were monitored at every 5 min during the rest period of training session. Blood pressure was recorded using a sphygmomanometer and a stethoscope (Premium, Rio de Janeiro, Brazil), heart rate and the peripheral oxygen saturation with a pulse oximeter (Ônix 9500, Nonin Medical Inc., Plymouth, MN, USA) and perceived effort with the Borg scale.

For the Sham group, the platform was modified with an externally motor coupled at its base. This apparatus was developed to reproduce the sound of the connected platform. The vibration generated by this apparatus is limited to the external motor and its protective case, being not sufficient to produce any physiological effect ([@b29-jer-14-5-883]), allowing to blind the patients regarding to the applied intervention throughout the training.

Statistical analysis
--------------------

The Shapiro--Wilk test was used to determine whether the variables were normally distributed. For the variables Clam and RFDr at 100 and 200 msec which were not normally distributed, the data are in median±interquartile range and Mann--Whitney was used to between group's comparisons. The variables Clam and RFDr at 30 and 50 msec are in mean±standard error and Student *t*-test was used to between group's comparisons. Data obtained after the intervention period were normalized by the baseline measures to obtain percent changes of each group and allowing group comparisons independently of baseline discrepancies.

A significance level of *P*\<0.05 was used for all statistical procedures, and all statistical analyses were performed using IBM SPSS Statistics ver. 21.0 (IBM Co., Armonk, NY, USA).

RESULTS
=======

Baseline characteristics of sociodemographic, anthropometric and laboratory data from selected patients are presented in [Table 1](#t1-jer-14-5-883){ref-type="table"}. The absolute values (i.e., nonnormalized values) of the explosive force parameters (CImp and RFDr) did not exhibit significant differences between groups before and after training ([Table 2](#t2-jer-14-5-883){ref-type="table"}).

The normalized CImp and RFDr reduced significantly less in CKD patients submitted to 3 months of WBV training when compared to sham group ([Figs. 2](#f2-jer-14-5-883){ref-type="fig"}, [3](#f3-jer-14-5-883){ref-type="fig"}). Normalized explosive force parameters obtained at the early phase of force/time curve reduced after the intervention period, with a significantly greater decline for the CKD patients submitted to the sham intervention for the CImp at 50 msec and RFDr at 30 and 50 msec: CImp: 30 msec (\~−22% and −49%, *P*=0.103), 50 ms (\~−15% and −51%, *P*=0.038); RFDr: 30 msec (\~−22% and −52%, *P*=0.044), 50 ms (\~−11 and −54%, *P*=0.008) (for the WBV training and sham groups, respectively). For the parameters obtained at the late phase there was an lower decline for WBV group when compared to sham group: CImp: 100 msec (\~−8% and −55%, *P*=0.025), 200 msec (\~−3% and −46%, *P*=0.025); RFDr 100 msec (\~0.01% and −56%, *P*=0.033), 200 msec (\~−5% and −36%, *P*=0.004) (for the WBV training and sham groups, respectively).

DISCUSSION
==========

The present study aimed to evaluate whether WBV training may improve explosive force (Clam and RFDr) of the knee extensor muscles in CKD patients. Our main find indicated that 3 months of WBV training is potentially useful for to attenuate the explosive force reduction of these patients.

This positive effect of WBV training in CKD patients contradicts partially our hypothesis that there would be an increase in the parameters of explosive force. This apparently divergence may be explained by the clinical condition of the patients. In fact, about 50% of patients undergoing HD have lower limb myopathy ([@b3-jer-14-5-883]), which is strongly related to the risk of increased mortality in these patients ([@b25-jer-14-5-883]).

Additionally, previous studies with elders observed improvements in the explosive strength and power of knee extensors after WBV when associated with other exercises ([@b6-jer-14-5-883]; [@b39-jer-14-5-883]), but it is possible that the WBV alone may avoid the great explosive force decline associated to CKD and HD, but could not be sufficient to induce significant increases in this variable. The results from [@b22-jer-14-5-883] may support this hypothesis, since they also observed that 10-week WBV training, for community-dwelling healthy elders, attenuated the decline but not provided significant muscle power improvements, while the control group experienced a significant decline of this variable.

The WBV is considered a safe and tolerable method to improve muscular performance ([@b4-jer-14-5-883]; [@b15-jer-14-5-883]), however no study was found evaluating the effects of WBV on the explosive force of CDK patients. In fact, has been suggested ([@b10-jer-14-5-883]; [@b33-jer-14-5-883]) that WBV can be applied to subjects unable to perform standard exercises, or to ones that the standard exercises are not suitable or well supported, owing to the physical weakness, as elders and CKD patients.

According to our results, previous studies showed no increase in muscle force gains after WBV training. In healthy elders, 6 weeks of WBV training did not increase maximal isokinetic strength of knee extensors and flexors ([@b28-jer-14-5-883]), and in stroke patients, 8 weeks of WBV training does not increases the maximum strength ([@b27-jer-14-5-883]).

Although the explosive force has not increased in the present study, the decline attenuation generated by WBV training may be considered clinically useful outcome. The explosive force is important to prevent fall episodes in physically weakened populations, since postural reactions required to avoid falls after a sudden postural perturbation occur between 0--250 msec after the onset of muscle activity ([@b1-jer-14-5-883]).

The explosive force depends on neural and muscular factors, so that it is usually analyzed/interpreted in two phases: (a) the early phase, comprising the first 0--50 msec, which depends more of neural factors; (b) the late phase, comprising the 100--200 msec, more associated to muscle properties ([@b1-jer-14-5-883]; [@b23-jer-14-5-883]). Based on this knowledge, in the present study, the attenuation in the explosive force reduction seem to be associated to both neural and muscular adaptations, since it were observed significant differences between WBV and SHAM groups in early and late phase of explosive force parameters.

The influence of WBV on neural factors may be explained by the activation of the TVR through changes in the sensitivity of the Ia afferents ([@b4-jer-14-5-883]; [@b11-jer-14-5-883]), while muscular adaptations are probability associated to muscle cross-sectional area ([@b22-jer-14-5-883]). Despite the low load involved in the WBV training, an attenuation of muscle hypotrophy in CDK patients could be plausible. In fact, it has been previously shown that 40 weeks of WBV without additional exercise promoted maintenance of the cross-sectional area in lower limbs of paraplegic patients ([@b24-jer-14-5-883]). In addition, when associated with squatting exercises, 10 weeks of WBV may induce hypertrophy in older adults ([@b22-jer-14-5-883]).

Data regarding the effects of WBV training in CKD patients are scarce. Recent pilot studies indicated that WBV training has the potential to attenuate bone deficits and improve physical function in this population ([@b16-jer-14-5-883]; [@b30-jer-14-5-883]). Our results may be of great clinical importance in the treatment of people with CKD. Considering that this population has a high risk of falls, owing to the disease and HD treatment ([@b17-jer-14-5-883]), attenuation of explosive force reduction may be useful to prevent such events. In fact, further studies should analyze the relationship between explosive force and clinical tests to evaluate falls risk (e.g., functional performance tests, balance tests, questionnaires, and others).

Recruit a homogeneous sample was a challenge, since CKD could be associated to many comorbidities and exhibit a wide range of clinical presentations. In addition, the long period of exercise training (3 months) leaded many patients to decline the invitation to engage in our study. Both factors limited the sample size and generated considerable discrepancies in baseline data (HD time and creatinine levels; see [Table 1](#t1-jer-14-5-883){ref-type="table"}), which constitute limitations of our study. Further studies should consider an increase in the sample size and association of WBV training with other interventions (e.g., kinesiotherapy, hydrotherapy, and others), since the WBV training was the unique intervention applied here. Analysis of muscle size and electromyographic activity also may improve the understanding of the mechanisms underlying explosive force parameters.

Three months of WBV may attenuate the explosive force reduction of the knee extensors in CKD patients. This intervention is therefore a potential tool for treatment programs aimed to improve the motor performance in this frail people, which could benefit the prevention of falls events, improving the quality of life of this population.
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![Normalized contractile impulse (post/pre) from chronic kidney disease patients submitted to 3 months of whole body vibration (WBV) training or sham. \*Significant difference between groups (*P*\<0.05). Red line indicates the reference value (i.e., the value where measure obtained post training period was equal to pre training). Data from normalized CImp at 30 and 50 msec are presented as mean±standard error, while data at 100 and 200 msec are presented as median±interquartile range.](jer-14-5-883f2){#f2-jer-14-5-883}

![Normalized relative rate of force development (RFDr) (POST/PRE) from chronic kidney disease patients submitted to three months of whole body vibration (WBV) training or sham. \*Significant difference between groups (*P*\<0.05). Red line indicates the reference value (i.e., the value where measure obtained post training period was equal to pre training). Data from normalized RFDr at 30 and 50 msec are presented as mean±standard error, while data at 100 and 200 msec are presented as median±interquartile range.](jer-14-5-883f3){#f3-jer-14-5-883}

###### 

Baseline anthropometric and laboratory characteristics of patients in the WBV and sham groups

  Variable                 WBV (n=7)      Sham (n= 7)    *P*-value
  ------------------------ -------------- -------------- ----------------------------------------------------
  Sex, male:female (%)     85.7:14.3      57.1:42.9      
                                                         
  Age (yr)                 62.42±10.32    53.28±8.26     0.092
                                                         
  Weight (kg)              71.94±8.85     73.80±15.99    0.793
                                                         
  Height (m)               1.61±0.07      1.59±0.08      0.656
                                                         
  BMI (kg/m^2^)            27.75±3.61     28.83±5.38     0.667
                                                         
  Time of HD (mo)          41.86±29.70    98.14±96.66    0.167
                                                         
  Laboratory parameter                                   
   Urea (mg/dL)            145.71±35.57   152.42±27.33   0.699
   Creatinine (mg/dL)      9.14±2.89      13.88±2.70     0.009[\*](#tfn3-jer-14-5-883){ref-type="table-fn"}
   Calcium (mg/dL)         8.84±0.77      8.77±0.28      0.822
   Phosphorus (mL)         5.31±1.81      6.24±2.22      0.408
   Sodium (mEq)            134.14±5.30    137.57±4.42    0.214
   Potassium (mEq)         4.75±1.15      4.84±0.65      0.869
   Hemoglobin (g/100 mL)   11.76±1.07     12.05±1.67     0.707
   Hematocrit (%)          35.72±2.59     36.90±4.65     0.572
   Albumin (g/dL)          3.91±0.21      4.02±0.28      0.413

Values are presented as mean±standard deviation unless otherwise indicated.

WBV, whole body vibration; BMI, body mass index; HD, hemodialysis.

*P*\<0.05.

###### 

Explosive force parameters from whole body vibration and sham groups at baseline (pre) and post training (post)

  Variable                                                                   WBV (n=7)     Sham (n=7)                 
  -------------------------------------------------------------------------- ------------- ------------- ------------ -----------
  CImp at 30 msec (N.m/sec)                                                  0.43±0.15     0.35±0.15     0.34±0.10    0.19±0.10
                                                                                                                      
  CImp at 50 msec (N.m/sec)                                                  1.33±0.47     1.09±0.44     1.07±0.31    0.58±0.30
                                                                                                                      
  CImp at 100 msec (N.m/sec)[a)](#tfn6-jer-14-5-883){ref-type="table-fn"}    4.25±7.98     4.16±4.32     4.93±6.70    1.07±3.05
                                                                                                                      
  CImp at 200 msec (N.m/sec)[a)](#tfn6-jer-14-5-883){ref-type="table-fn"}    16.56±22.87   16.07±13.56   14.07±15.8   3.23±8.46
                                                                                                                      
  RFDr at 30 msec (%MVC/sec)                                                 3.11±0.85     2.31±0.68     3.69±0.99    1.73±0.73
                                                                                                                      
  RFDr at 50 msec (%MVC/sec)                                                 3.52±0.98     2.78±0.72     4.27±1.08    1.97±0.81
                                                                                                                      
  RFDr at 100 msec (%MVC/sec)[a)](#tfn6-jer-14-5-883){ref-type="table-fn"}   2.10±3.39     2.53±1.90     5.09±4.98    0.97±2.69
                                                                                                                      
  RFDr at 200 msec (%MVC/sec)[a)](#tfn6-jer-14-5-883){ref-type="table-fn"}   2.22±1.84     2.21±1.38     2.99±2.92    1.15±1.67

Values are presented as mean±standard error unless otherwise indicated.

CImp, contractile impulse; RFDr, relative rate of force development.

Values presented as median±interquartile range. No significant difference between the groups before and after the interventions.
